Comparing the attitudes of physicians and non-physicians toward communicating a patient’s BRCA1 mutation to a first-degree relative against a patient’s wishes
Tóm tắt
Although genetic testing can be vastly informative, it creates a dilemma if a patient does not want to disclose an abnormal genetic test to at-risk relatives. A sample of 200 participants from Nevada (100 physicians, 100 non-physicians) completed an 11-item questionnaire asking demographic information, familiarity with genetics and genetic testing, and opinions about a physician’s role in a hypothetical case in which a patient does not wish to communicate her BRCA1 mutation to her sister. Although most respondents did not think the physician should notify the sister against the patient’s wishes, more non-physicians (40%) than physicians (23%) contended that the physician should do so (p = 0.0119). Most respondents from both groups agreed that the physician should not have the legal duty to notify the sister, would not be morally justified in sharing genetic test results with the sister, but should have the right to notify a patient’s relatives if the disease is “serious, preventable, and treatable.” More non-physicians than physicians agreed that physicians should have an educational requirement on how to communicate genetic test results to patients and their family (88% vs 65%, p = 0.0002). Most physicians (70%) reported a familiarity/strong familiarity with genetic testing compared to non-physicians (33%; p < 0.0001). Future qualitative research should assess physicians’ understanding of issues surrounding familial communication of genetic test results. Educational interventions to facilitate effective communication to patients and families are needed and welcomed by most physicians. Discrepancies between the attitudes of physicians and patients or the public need to be better understood and addressed.
Tài liệu tham khảo
Akpinar A, Ersoy N (2014) Attitudes of physicians and patients toward disclosure ofgenetic information to spouse and first-degree relatives: a case study from Turkey. BMC Med Ethics 15:39
American Cancer Society (2021) Genes and cancer. https://www.cancer.org/cancer/cancer-causes/genetics/genes-and-cancer.html. Accessed 15 Dec 2021
American Medical Association. Council on Ethical and Judicial Affairs (2012) Disclosureof familial risk in genetic testing. https://journalofethics.ama-assn.org/article/ama-code-medical-ethics-opinion-disclosure-patients-genetic-test-results/2012-08. Accessed 10 Jan 2022
American Society of Clinical Oncology (2003) ASCO policy statement update: genetictesting for cancer susceptibility. J Clin Oncol 21(12):2397–2406
ASHG statement (1998) Professional disclosure of familial genetic information. TheAmerican Society of Human Genetics Social Issues Subcommittee on Familial Disclosure. Am J Hum Genet 62(2):474-483
Branum R, Wolf SM (2015) International policies on sharing genomic research results with relatives: approaches to balancing privacy and access. J Law Med Ethics 43(3):576–593
Centers for Disease Control and Prevention (2020) Genetic counseling. https://www.cdc.gov/genomics/gtesting/genetic_counseling.htm. Accessed 5 Jan 2022
Clayton EW, Evans BJ, Hazel JW, Rothstein MA (2019) The law of genetic privacy: applications, implications, and limitations. J Law Biosci 6(1):1–36
Cragun D, Camperlengo L, Robinson E, Caldwell M, Kim J, Phelan C, Monteiro AN, Vadaparampil ST, Sellers TA, Pal T (2015) Differences in BRCA counselling and testing practices based on ordering provider type. Genet Med 17(1):51–57
Dheensa S, Fenwich A, Lucassen A (2016a) ‘Is this knowledge mine and nobody else’s? I don’t feel that’. Patient views about consent, confidentiality and information-sharing in genetic medicine. J Med Ethics 42:174–179
Dheensa S, Fenwick A, Shkedi-Rafid S, Crawford G, Lucassen A (2016b) Health-care professionals’ responsibility to patients’ relatives in genetic medicine: a systematic review and synthesis of empirical research. Genet Med 18(4):290–301
Dheensa S, Fenwich A, Lucassen A (2017) Approaching confidentiality at a familial level in genomic medicine: a focus group study with health care professionals. Br Med J Open 7(2):1–10
Gallo AM, Angst DB, Knafl KA (2009) Disclosure of genetic information withinfamilies. Am J Nurs 109(4):65–69
Gammon A, Neklason DW (2015) Confidentiality & the risk of geneticdiscrimination. Surg Oncol Clin N Am 24(4):667–681
Greenburg M, Smith RA (2016) Support seeking or familial obligation: an investigation of motives for disclosing genetic test results. Health Commun 31(6):668–678
Griswold T, Packham J, Etchegoyhen L, Young V, Friend J (2019) Nevada Ruraland Frontier Health Data Book (9th ed.). Nevada Health Workforce Research Center
Healthy Nevada Project (2016) Healthy NV Project. http://healthynv.org/. Accessed 19 Dec 2021
Heaton TJ, Chico V (2016) Attitudes towards the sharing of genetic information with at-risk relatives: results of a quantitative survey. Hum Genet 135:109–120
Henrikson NB, Waner JK, Hampel H, DeVore C, Shridhar N, Williams JL, Donohue KE, Kullo I, Prince AE (2020) What guidance does HIPAA offer to providers considering familial risk notification and cascade genetic testing? J Law Biosci 7(1):1–14
Horton RH, Lucassen AM (2019) Recent developments in genetic/genomic medicine. Clin Sci 133(5):697–708
Laberge A, Burke W (2009) Duty to warn at-risk family members of genetic disease. AMA Journal of Ethics. Virtual Mentor 11(9):656–660
Marchant G, Barnes M, Evans JP, LeRoy B, Wolf SM (2020) From genetics to genomics: facing the liability implications in clinical care. J Law Med Ethics 48:11–43
National Cancer Institute (2019) BRCA gene mutations: cancer risk and genetic testing. https://www.cancer.gov/about-cancer/causes-prevention/genetics/brca-fact-sheet Accessed 20 Dec 2021
National Human Genome Research Institute (2020) Genome statue and legislation database. https://www.genome.gov/about-genomics/policy-issues/Genome-Statute-Legislation-Database. Accessed 5 April 2022
National Society of Genetic Counselors (2020) About genetic counselors. https://www.nsgc.org/About/About-Genetic-Counselors Accessed 3 Jan 2022
Nevada State Board of Medical Examiners (2019) http//medboard.nv.gov/. Accessed 4 January 2022
NRS 49.225 (1971) General rule of privilege. https://www.leg.state.nv.us/nrs/nrs-049.html Accessed 31 Jan 2022
Parker M, Lucassen A (2004) Genetic information: a joint account? Br Med J 329:165–167
Phillips A, Niemiec E, Howard HC, Kagkelari K, Borry P, Vears DF (2020) Communicating genetic information to family members: analysis of consent forms for diagnostic genomic sequencing. Eur J Hum Genet 28:1160–1167
Phillips A, Borry P, Van Hoyweghen I, Vears DF (2021) Disclosure of genetic information to family members: a systemic review of normative documents. Genet Med 23:2038–2046
Rothstein M (2018) Reconsidering the duty to warn genetically at-risk relatives. Genet Med 20(3):285–290
Schaibley VM, Ramos IN, Woosley RL, Curry S, Hays S, Ramos KS (2022) Limited genomics training among physicians remains a barrier to genomics-based implementation of precision medicine. Front Med 9:1–6
Schleiter KE (2009) A physician’s duty to warn third parties of hereditary risk. AMA J Ethics 11(9):697–700
Srinivasan S, Won NY, Dotson WD, Wright ST, Roberts MC (2020) Barriers and facilitators for cascade testing in genetic conditions: a systemic review. Eur J Hum Genet 28(12):1631–1644
Stoppler M C (2019) Genetic diseases (disorder definition, types, and examples).MedicineNet. https://www.medicinenet.com/genetic_disease/article.htm. Accessed 4 Jan 2022
Wendelsdorf K (2018) You have a genetic disorder: should your family be told they mightcarry the mutation? Genetic Literacy Project. https://geneticliteracyproject.org/2013/10/01/you-have-a-genetic-disorder-should-your-family-be-told-they-too-might-carry-the-harmful-mutation/ Accessed 3 Jan 2022
Zimmern RL, Khoury MJ (2012) The impact of genomics on public health practice: the case for change. Public Health Genomics 15(3–4):118–124